WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Transplant Product Efficacy Framework-colored-v2-r1, Graft Loss can be assessed at defined time point, defined time point including 12 months, Decreased GFR is associated with Cardiovascular (CV) risk, Glomerular Filtration Rate (GFR) can be measured by cold-iothalamate method, Death can be assessed at defined time point, defined time points between 3 months, BPAR (Biopsy Proven Acute Rejection) can be confirmed as BCAR (Biopsy Confirmed Acute Rejection), urine output is measured as decreased, Acute Rejection Events include Graft Loss, BCAR (Biopsy Confirmed Acute Rejection) is assessed by Biopsy, Flow rates can be thresholded at 60 mL/min, defined time point including 12 months, Date of Graft Loss is earliest occurance of Death, Renal function/ Impairment leads to Long Term Dialysis, Graft Loss is the inverse of Graft Survival, Clinically suspected Acute Rejection can be defined by graft tenderness, Study treatments include Belatacept, Banff grade can be IIA, Death is assessed at Follow-up, Glomerular Filtration Rate (GFR) is measured as Elevated GFR